Literature DB >> 11967140

Effectiveness of washed platelet concentrate and red cell transfusions for a patient with anhaptoglobinemia with antihaptoglobin antibody.

S Nishiki1, M Hino, T Kumura, S Hashimoto, K Ohta, T Yamane, T Takubo, N Tatsumi, S Kitagawa, T Kamitani, Y Watanabe, E Shimada, T Juji, S Iida.   

Abstract

A 71-year-old Japanese male with myelodysplastic syndrome progressing to overt leukaemia and hepatocellular carcinoma developed dyspnea and urticaria immediately after infusion of platelet concentrate (PC). He exhibited an identical reaction following blood transfusion. Serum haptoglobin was undetectable. The patient was determined to be homozygous for Hp(del) by polymerase chain reaction (PCR). Antibody to haptoglobin was detected by enzyme-linked immunosorbent assay (ELISA) and Western blot analysis. No antibodies against human leucocyte antigen (HLA) or platelet-specific antigens were detected. Washed PC and washed red blood cells were effective in preventing the transfusion-related anaphylactoid reactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967140     DOI: 10.1046/j.1365-3148.2002.00350.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  3 in total

1.  Rapid detection of haptoglobin gene deletion in alkaline-denatured blood by loop-mediated isothermal amplification reaction.

Authors:  Mikiko Soejima; Kouichi Egashira; Hiroyuki Kawano; Atsushi Kawaguchi; Kimitaka Sagawa; Yoshiro Koda
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

2.  A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients.

Authors:  Katie L Thoren; Scott T Avecilla; Virginia Klimek; Cheryl Goss
Journal:  Transfusion       Date:  2020-01-23       Impact factor: 3.157

3.  Anaphylactic transfusion reaction in a patient with anhaptoglobinemia: the first case in Korea.

Authors:  Hyunsoo Kim; Jonghyeon Choi; Kyoung Un Park; Hyon-Suk Kim; Yoo Hong Min; Moon Jung Kim; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.